Spots Global Cancer Trial Database for Study Using CP-461 to Treat Advanced Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study Using CP-461 to Treat Advanced Prostate Cancer
Official Title:
Study ID: NCT00036075
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to investigate whether an investigational drug, CP-461, is safe and effective for the treatment of patients with prostate cancer and who have measurable disease.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Columbia Presbyterian Medical Center, New York, New York, United States
University of Washington, Seattle, Washington, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
